Cargando…

Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study

OBJECTIVE: To evaluate changes over 3 years in the thickness of inner retinal layers including the peripapillary retinal nerve fiber layer (pRNFL), and combined macular ganglion cell and inner plexiform layers (mGCIPL), in individuals with relapsing‐remitting multiple sclerosis (RRMS) versus healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Friedemann, Calabresi, Peter A., Barkhof, Frederik, Green, Ari J., Kardon, Randy, Sastre‐Garriga, Jaume, Schippling, Sven, Vermersch, Patrick, Saidha, Shiv, Gerendas, Bianca S., Schmidt‐Erfurth, Ursula, Agoropoulou, Catherine, Zhang, Ying, Seifer, Gustavo, Petzold, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670323/
https://www.ncbi.nlm.nih.gov/pubmed/34792863
http://dx.doi.org/10.1002/acn3.51473
_version_ 1784614956443893760
author Paul, Friedemann
Calabresi, Peter A.
Barkhof, Frederik
Green, Ari J.
Kardon, Randy
Sastre‐Garriga, Jaume
Schippling, Sven
Vermersch, Patrick
Saidha, Shiv
Gerendas, Bianca S.
Schmidt‐Erfurth, Ursula
Agoropoulou, Catherine
Zhang, Ying
Seifer, Gustavo
Petzold, Axel
author_facet Paul, Friedemann
Calabresi, Peter A.
Barkhof, Frederik
Green, Ari J.
Kardon, Randy
Sastre‐Garriga, Jaume
Schippling, Sven
Vermersch, Patrick
Saidha, Shiv
Gerendas, Bianca S.
Schmidt‐Erfurth, Ursula
Agoropoulou, Catherine
Zhang, Ying
Seifer, Gustavo
Petzold, Axel
author_sort Paul, Friedemann
collection PubMed
description OBJECTIVE: To evaluate changes over 3 years in the thickness of inner retinal layers including the peripapillary retinal nerve fiber layer (pRNFL), and combined macular ganglion cell and inner plexiform layers (mGCIPL), in individuals with relapsing‐remitting multiple sclerosis (RRMS) versus healthy controls; to determine whether optical coherence tomography (OCT) is sufficiently sensitive and reproducible to detect small degrees of neuroaxonal loss over time that correlate with changes in brain volume and disability progression as measured by the Expanded Disability Status Scale (EDSS). METHODS: Individuals with RRMS from 28 centers (n = 333) were matched with 64 healthy participants. OCT scans were performed on Heidelberg Spectralis machines (at baseline; 1 month; 6 months; 6‐monthly thereafter). RESULTS: OCT measurements were highly reproducible between baseline and 1 month (intraclass correlation coefficient >0.98). Significant inner retinal layer thinning was observed in individuals with multiple sclerosis (MS) compared with controls regardless of previous MS‐associated optic neuritis––group differences (95% CI) over 3 years: pRNFL: −1.86 (−2.54, −1.17) µm; mGCIPL: −2.03 (−2.78, −1.28) µm (both p < 0.0001; effect sizes 0.39 and 0.34). Greater inner retinal layer atrophy was observed in individuals diagnosed with RRMS <3 years versus >5 years (pRNFL: p < 0.05; mGCIPL: p < 0.01). Brain volume decreased by 1.3% in individuals with MS over 3 years compared to 0.5% in control subjects (effect size 0.76). mGCIPL atrophy correlated with brain atrophy (p < 0.0001). There was no correlation of OCT data with disability progression. INTERPRETATION: OCT has potential to estimate rates of neurodegeneration in the retina and brain. The effect size for OCT, smaller than for magnetic resonance imaging based on Heidelberg Spectralis data acquired in this study, was increased in early disease.
format Online
Article
Text
id pubmed-8670323
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86703232021-12-21 Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study Paul, Friedemann Calabresi, Peter A. Barkhof, Frederik Green, Ari J. Kardon, Randy Sastre‐Garriga, Jaume Schippling, Sven Vermersch, Patrick Saidha, Shiv Gerendas, Bianca S. Schmidt‐Erfurth, Ursula Agoropoulou, Catherine Zhang, Ying Seifer, Gustavo Petzold, Axel Ann Clin Transl Neurol Research Articles OBJECTIVE: To evaluate changes over 3 years in the thickness of inner retinal layers including the peripapillary retinal nerve fiber layer (pRNFL), and combined macular ganglion cell and inner plexiform layers (mGCIPL), in individuals with relapsing‐remitting multiple sclerosis (RRMS) versus healthy controls; to determine whether optical coherence tomography (OCT) is sufficiently sensitive and reproducible to detect small degrees of neuroaxonal loss over time that correlate with changes in brain volume and disability progression as measured by the Expanded Disability Status Scale (EDSS). METHODS: Individuals with RRMS from 28 centers (n = 333) were matched with 64 healthy participants. OCT scans were performed on Heidelberg Spectralis machines (at baseline; 1 month; 6 months; 6‐monthly thereafter). RESULTS: OCT measurements were highly reproducible between baseline and 1 month (intraclass correlation coefficient >0.98). Significant inner retinal layer thinning was observed in individuals with multiple sclerosis (MS) compared with controls regardless of previous MS‐associated optic neuritis––group differences (95% CI) over 3 years: pRNFL: −1.86 (−2.54, −1.17) µm; mGCIPL: −2.03 (−2.78, −1.28) µm (both p < 0.0001; effect sizes 0.39 and 0.34). Greater inner retinal layer atrophy was observed in individuals diagnosed with RRMS <3 years versus >5 years (pRNFL: p < 0.05; mGCIPL: p < 0.01). Brain volume decreased by 1.3% in individuals with MS over 3 years compared to 0.5% in control subjects (effect size 0.76). mGCIPL atrophy correlated with brain atrophy (p < 0.0001). There was no correlation of OCT data with disability progression. INTERPRETATION: OCT has potential to estimate rates of neurodegeneration in the retina and brain. The effect size for OCT, smaller than for magnetic resonance imaging based on Heidelberg Spectralis data acquired in this study, was increased in early disease. John Wiley and Sons Inc. 2021-11-18 /pmc/articles/PMC8670323/ /pubmed/34792863 http://dx.doi.org/10.1002/acn3.51473 Text en © 2021 Novartis Pharma AG. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Paul, Friedemann
Calabresi, Peter A.
Barkhof, Frederik
Green, Ari J.
Kardon, Randy
Sastre‐Garriga, Jaume
Schippling, Sven
Vermersch, Patrick
Saidha, Shiv
Gerendas, Bianca S.
Schmidt‐Erfurth, Ursula
Agoropoulou, Catherine
Zhang, Ying
Seifer, Gustavo
Petzold, Axel
Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study
title Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study
title_full Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study
title_fullStr Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study
title_full_unstemmed Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study
title_short Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study
title_sort optical coherence tomography in multiple sclerosis: a 3‐year prospective multicenter study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670323/
https://www.ncbi.nlm.nih.gov/pubmed/34792863
http://dx.doi.org/10.1002/acn3.51473
work_keys_str_mv AT paulfriedemann opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT calabresipetera opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT barkhoffrederik opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT greenarij opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT kardonrandy opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT sastregarrigajaume opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT schipplingsven opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT vermerschpatrick opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT saidhashiv opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT gerendasbiancas opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT schmidterfurthursula opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT agoropouloucatherine opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT zhangying opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT seifergustavo opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy
AT petzoldaxel opticalcoherencetomographyinmultiplesclerosisa3yearprospectivemulticenterstudy